TMD Titan Medical merger with Conavi is great news for sharePatience has paid off for TMD share holders. The merger details are set to be finalized by July . This stock is expected to start at 0.30 which is triple it's current stock price. https://ir.titanmedicalinc.com/news-events/press-releases/detail/403/titan-announces-merger-agreement-with-conavi
With Conavi’s commercial hybrid imaging technology and anticipated financial resources from the merger and financing, the combined company aims to drive market penetration in the fast-growing field of intravascular imaging for coronary procedures. The deal transforms Titan from an R&D-stage firm into a revenue-generating medtech leader.